LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice

논문상세정보
' LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • High-density lipoprotein cholesterol (HDL-chol)
  • LJ-1888
  • Low-density lipoprotein cholesterol (LDL-chol)
  • Atherosclerosis
  • Hypercholesterolemia
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
155 0

0.0%